Lack of weight gain and relapse risk in a large tuberculosis treatment trial

American Journal of Respiratory and Critical Care Medicine

Volumn 174, Issue 3, 2006, Pages 344-348

  Khan, Awal ^a   Sterling, Timothy R ^b   Reves, Randall ^b   Vernon, Andrew ^b   Horsburgh, C Robert ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NONE

Author keywords

Body mass index; Clinical trial; Relapse; Tuberculosis; Weight

Indexed keywords

RIFAMPICIN; RIFAPENTINE;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; TUBERCULOSIS; UNDERWEIGHT; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; ANTITUBERCULAR AGENTS; BODY MASS INDEX; BODY WEIGHT; FEMALE; HUMANS; ISONIAZID; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RIFAMPIN; RISK FACTORS; THINNESS; TUBERCULOSIS; WEIGHT GAIN;

EID: 33746616360     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200511-1834OC     Document Type: Article

References (15)

1. van Lettow M, Harries AD, Kumwenda JJ, Zijlstra EE, Clark TD, Taha TE, Semba RD. Micronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and without HIV co-infection in Malawi. BMC Infect Dis 2004;4:61.
2. Onwubalili JK. Malnutrition among tuberculosis patients in Harrow, England. Eur J Clin Nutr 1988;42:363-366.
3. Harries AD, Nkhoma WA, Thompson PJ, Nyangulu DS, Wirima JJ. Nutritional status in Malawian patients with pulmonary tuberculosis and response to chemotherapy. Eur J Clin Nutr 1988;42:445-450.
4. Cegielski JP, McMurray DN. The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis 2004;8:286-298.
5. Edwards LB, Livesay VT, Acquaviva FA, Palmer CE. Height, weight, tuberculous infection, and tuberculous disease. Arch Environ Health 1971;22:106-112.
6. Tverdal A. Body mass index and incidence of tuberculosis. Eur J Respir Dis 1986;69:355-362.
7. The Tuberculosis Trials Consortium. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomized clinical trial. Lancet 2002;360:528-534.
8. Khan A, Reves R, Sterling T, Vernon A, Weis S; Tuberculosis Trials Consortium. Weight, body mass index, and treatment outcome in a large TB treatment trial (TBTC Study 22) [abstract]. Am J Respir Crit Care Med 2002;165:A293.
9. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Am J Clin Nutr 1998;68:899-917.
10. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998;6:51S-209S.
11. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B,Hermans P, Martin C, McAdam R, Shinnick TM, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-409.
12. Jasmer RM, Bozeman L, Schwartzman K, Cave MD, Saukkonen JJ, Metchock B, Khan A, Burman WJ. Recurrent tuberculosis in the United States and Canada: relapse or reinfection? Am J Respir Crit Care Med 2004;170:1360-1366.
13. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-662.
14. Mitchison DA. Role of individual drugs in the chemotherapy of tuberculosis. Int J Tuberc Lung Dis 2000;4:796-806.
15. Zhang Y, Mitchison D. The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis 2003;7:6-21.